SO
77
-3
PX
46
-2
NUE
39
-2
CSX
46
7
CAG
46
-2
AME
68
6
HRB
83
-2
SBUX
39
4
FTI
69
-9
VIX
25
3
BWA
42
-6
LH
46
-3
LMT
52
-2
AVGO
52
-5
NOV
34
-8
DGX
46
-2
LUV
59
-3
UHS
58
-2
BMY
35
2
PEG
51
-6
SO
77
-3
PX
46
-2
NUE
39
-2
CSX
46
7
CAG
46
-2
AME
68
6
HRB
83
-2
SBUX
39
4
FTI
69
-9
VIX
25
3
BWA
42
-6
LH
46
-3
LMT
52
-2
AVGO
52
-5
NOV
34
-8
DGX
46
-2
LUV
59
-3
UHS
58
-2
BMY
35
2
PEG
51
-6
Financhill
Back

Sonnet BioTherapeutics Holdings Vs. Amylyx Pharmaceuticals Industry Stock Comparison

Sell
24

SONN
Sonnet BioTherapeutics Holdings

Last Price:
1.50
Seasonality Move:
-13.87%
Sell
29

AMLX
Amylyx Pharmaceuticals

Last Price:
1.78
Seasonality Move:
87.32%
Sell
24
Sonnet BioTherapeutics Holdings (SONN) is a Sell

Is Sonnet BioTherapeutics Holdings a Buy, Sell or Hold?

  • The current Sonnet BioTherapeutics Holdings [SONN] share price is $1.74. The Score for SONN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • SONN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Amylyx Pharmaceuticals (AMLX) is a Sell

Is Amylyx Pharmaceuticals a Buy, Sell or Hold?

  • The current Amylyx Pharmaceuticals [AMLX] share price is $1.83. The Score for AMLX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • AMLX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SONN Stock Price Chart

What is Sonnet BioTherapeutics Holdings's stock price today?

  • The Sonnet BioTherapeutics Holdings share price today is $1.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SONN is experiencing slight buying pressure.

AMLX Stock Price Chart

What is Amylyx Pharmaceuticals's stock price today?

  • The Amylyx Pharmaceuticals share price today is $1.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing slight buying pressure.

SONN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 46.08 Sell
Chaikin Money Flow: 21261 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.73 - 1.85) Sell
Bollinger Bands (100): (1.51 - 1.97) Sell

AMLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 31.03 Sell
Chaikin Money Flow: 294140 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.8 - 1.96) Sell
Bollinger Bands (100): (1.86 - 15.96) Sell

SONN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.78 Sell
20-day SMA: 1.8 Sell
50-day SMA: 1.88 Sell
200-day SMA: 2.36 Sell
8-day EMA: 1.76 Sell
20-day EMA: 1.79 Sell
50-day EMA: 1.82 Sell
200-day EMA: 5.43 Sell

AMLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.83 Sell
20-day SMA: 1.87 Sell
50-day SMA: 2.28 Sell
200-day SMA: 13.08 Sell
8-day EMA: 1.84 Sell
20-day EMA: 1.98 Sell
50-day EMA: 3.83 Sell
200-day EMA: 12.07 Sell

Sonnet BioTherapeutics Holdings Earnings Growth & SONN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.01 per share, and a decrease next year of $0.35 per share.

Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.01 per share, an increase next quarter of $0.14 per share, a decrease this year of $2.19 per share, and a decrease next year of $0.28 per share.

Sonnet BioTherapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amylyx Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):